NEWS

Recent News

NantCell Announces New Celgene Investment

Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7thSecond Round Crossover Funding Brings Celgene’s Investment to $105M in NantCellValued at $4 BillionCurrently Enrolling Patients in Advanced...

NantKwest to Participate at Upcoming Investment Conferences

CULVER CITY, CALIFORNIA-, November 12, 2018 NantKwest (Nasdaq:NK), a leading clinical-stage, natural killer cell based therapeutics company, today announced that the company will be participating at a number of investment conferences during the month of...

NantKwest to Present at 2018 Cantor Global Healthcare Conference

CULVER CITY, CALIFORNIA, September 26, 2018 NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting at the upcoming Cantor Global Healthcare Conference on Tuesday, October 2nd...

NantKwest to Participate in Upcoming Investment Conferences

CULVER CITY, CA - August 30, 2018 - NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be participating at several upcoming investment conferences. During these conferences,...

Archives

Media Contact:

Jen Hodson
NantKwest
Telephone: 562-397-3639
Email: Press@NantKwest.com